| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 322.06M | 317.50M | 288.80M | 270.10M | 210.18M | 165.36M |
| Gross Profit | 251.18M | 186.70M | 165.80M | 153.40M | 122.49M | 93.82M |
| EBITDA | 40.26M | 235.00M | 140.80M | 110.80M | 187.60M | 175.61M |
| Net Income | 208.14M | 178.10M | 107.80M | 79.60M | 147.90M | 147.45M |
Balance Sheet | ||||||
| Total Assets | 3.37B | 3.27B | 2.60B | 2.39B | 2.39B | 1.52B |
| Cash, Cash Equivalents and Short-Term Investments | 425.47M | 571.30M | 214.50M | 99.20M | 127.28M | 49.30M |
| Total Debt | 1.45B | 1.35B | 982.90M | 1.00B | 1.02B | 483.04M |
| Total Liabilities | 1.66B | 1.58B | 1.19B | 1.19B | 1.20B | 593.17M |
| Stockholders Equity | 1.71B | 1.69B | 1.41B | 1.20B | 1.19B | 926.53M |
Cash Flow | ||||||
| Free Cash Flow | 131.53M | 71.10M | 103.50M | 79.70M | 54.42M | 37.17M |
| Operating Cash Flow | 137.89M | 133.10M | 146.10M | 113.40M | 81.75M | 71.00M |
| Investing Cash Flow | -342.50M | -207.10M | -66.30M | -41.80M | -429.51M | -73.53M |
| Financing Cash Flow | 309.65M | 429.10M | 42.60M | -98.60M | 431.75M | -53.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £1.57B | 4.93 | 12.27% | 5.71% | 4.80% | 37.75% | |
76 Outperform | £50.18M | 3.28 | 6.10% | 3.92% | -6.10% | 889.93% | |
68 Neutral | £343.11M | 8.24 | 5.35% | 5.88% | -6.52% | -20.26% | |
67 Neutral | £1.25B | 7.07 | 10.25% | 3.62% | -8.66% | 553.35% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
51 Neutral | £155.19M | -6.51 | -9.62% | ― | ― | ― | |
50 Neutral | £226.07M | 35.14 | 5.91% | 2.71% | -14.09% | ― |